Close

NanoViricides (NNVC), St. Jude Children's Research Hospital Enter Agreement on Anti-Influenza Program

May 31, 2016 7:10 AM EDT Send to a Friend
NanoViricides, Inc. (NYSE: NNVC) announced that it has entered into an agreement with St. Jude Children's Research Hospital, Memphis, TN ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login